WebSystemic lupus erythematosus (SLE) is an autoimmune disease that affects the cardiovascular, gastrointestinal, hematologic, integumentary, musculoskeletal, … Lung disease is a serious potential health condition that can develop in people with systemic sclerosis (scleroderma). Interstitial lung disease occurs in most, but not all people with the condition. It is the leading cause of death among people with systemic sclerosis. See more Systemic sclerosis is an autoimmune disease. Genetics and environmental factors likely play a role in triggering the disease, but much about the disease is unknown. Although … See more People with interstitial lung disease from systemic sclerosis are most often diagnosed after their initial diagnosis with systemic sclerosis. … See more The prognosis for people with interstitial lung disease from systemic sclerosis is usually not good. People who have interstitial lung disease along with systemic sclerosis are much more likely to die from disease … See more The treatment options for interstitial lung disease from systemic sclerosis are limited. Treatments like supplemental oxygen may help some people, while other treatments may … See more
Effect of internet-based pulmonary rehabilitation on physical …
WebSystemic lupus erythematosus (SLE) is an autoimmune disease that affects the cardiovascular, gastrointestinal, hematologic, integumentary, musculoskeletal, neuropsychiatric, pulmonary, renal, and ... smart collection 158
What to Know About Cystic Lung Disease – Cleveland Clinic
WebJul 29, 2024 · The pathogenesis of pulmonary involvement relates to separate mechanisms: direct involvement scleroderma-related interstitial lung disease (SSc-ILD) non-specific interstitial pneumonitis (NSIP): more common usual interstitial pneumonia (UIP) pattern: histologically indistinguishable from rheumatoid lung and idiopathic pulmonary fibrosis WebMar 26, 2024 · We conducted a systematic review and meta-analysis to evaluate the efficacy and safety of a short-acting muscarinic antagonist (SAMA) therapy combined with a long-acting beta-2 agonist (LABA) in patients with stable COPD. WebMay 3, 2024 · The incidence of nontuberculous mycobacterial (NTM) pulmonary disease caused by Mycobacterium avium complex (MAC) in apparently immune-competent people is increasing worldwide. We performed a systematic review of the published literature on five-year all-cause mortality in patients with MAC lung disease, and pooled the mortality rates … hillcrest prep boys basketball arizona